Childhood Respiratory Conditions: Nonasthma Chronic Lung Disease

Cori Daines1

  • 1Division of Pulmonary and Sleep Medicine in the Department of Pediatrics at University of Arizona College of Medicine, 1501 N. Campbell Ave, Tucson, AZ 85724.

FP Essentials
|February 10, 2022
PubMed

Insights

Bronchopulmonary dysplasia (BPD) and cystic fibrosis (CF) are chronic lung diseases impacting children and adults. Both conditions involve impaired lung development or function, leading to respiratory issues and complications throughout life.

Area of Science:

  • Pulmonology
  • Genetics
  • Pediatric Medicine

Background:

  • Bronchopulmonary dysplasia (BPD) is a chronic lung disease primarily affecting premature infants, often resulting from ventilatory support and leading to long-term pulmonary issues.
  • Cystic fibrosis (CF) is a genetic disorder caused by CFTR gene variations, characterized by mucus buildup in airways, chronic cough, and progressive lung function decline.

Purpose of the Study:

  • To provide a comprehensive overview of Bronchopulmonary dysplasia (BPD) and Cystic Fibrosis (CF).
  • To highlight the key features, complications, and management strategies for both conditions.
  • To discuss the impact of these diseases on pulmonary function and overall quality of life.

Main Methods:

  • Literature review of existing studies on BPD and CF.
  • Analysis of disease mechanisms, clinical manifestations, and treatment outcomes.
  • Synthesis of information regarding diagnosis, complications, and emerging therapies.

Main Results:

  • BPD affects premature infants, causing lifelong respiratory problems like asthma-like symptoms and increasing susceptibility to infections.
  • CF leads to chronic cough, recurrent infections, and progressive lung damage due to CFTR gene mutations.
  • Both conditions present significant challenges, including pulmonary hypertension, infections, and gastrointestinal issues, necessitating comprehensive management.

Conclusions:

  • Early diagnosis and intervention are crucial for managing BPD and CF.
  • Effective management requires addressing pulmonary, infectious, and associated systemic complications.
  • Advancements in CFTR modulators offer promising therapeutic avenues for improving longevity and quality of life in CF patients.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.0K
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
983
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.5K